Bone Biologics Corp (BBLG) Social Stream
BONE BIOLOGICS CORP (BBLG) Price Targets From Analysts
Use the tables below to see what analysts covering BONE BIOLOGICS CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-15 | 1 | $7.75 | $7.75 | $7.75 | $4.66 | 66.31% |
| 2022-10-18 | 1 | $7.75 | $2.251 | $5 | $4.66 | 7.3% |
| 2023-04-11 | 1 | $7.55 | $2.251 | $4.9 | $4.66 | 5.15% |
| 2023-04-13 | 1 | $7.55 | $2.25 | $4.9 | $4.66 | 5.15% |
| 2023-05-16 | 1 | $6.75 | $2.25 | $4.5 | $4.66 | -3.43% |
| 2023-06-08 | 1 | $67.567 | $14.25 | $40.908 | $4.66 | 777.85% |
| 2023-06-20 | 1 | $67.567 | $8 | $37.783 | $4.66 | 710.79% |
| 2023-11-15 | 1 | $67.567 | $7.5 | $37.533 | $4.66 | 705.43% |
Price Target Last Issued September 15, 2022
The Trend in the Analyst Price Target
Over the past 26 weeks, BBLG's average price target has gone up $33.03.
BBLG reports an average of 8,626.49% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 1 | 7.550 | 2.251 | 4.900 | 0.243 | 1916.46% |
| 2023-04-11 | 1 | 7.550 | 2.250 | 4.900 | 0.250 | 1860% |
| 2023-04-13 | 1 | 7.550 | 2.250 | 4.900 | 0.250 | 1860% |
| 2023-06-08 | 1 | 67.567 | 14.250 | 40.908 | 5.780 | 607.75% |
| 2023-08-15 | 1 | 67.567 | 7.500 | 37.533 | 0.812 | 4522.29% |
BBLG Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
BBLG's average broker recommendation rating improved by 0 over the prior 31 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, BONE BIOLOGICS CORP's number of analysts covering the stock is greater than practically none of them.
- BBLG has a lower variance in analysts' estimates than -741.38% of Medical Equipment stocks.
- In terms of how BONE BIOLOGICS CORP fares relative to Medical Equipment stocks, note that its upside potential (average analyst target price relative to current price) is higher than 536.77% of that group.
- In the context of Medical Equipment stocks, BONE BIOLOGICS CORP's average analyst price target is greater than 237.87% of them.
In the Medical Equipment industry, TIVC, NXL, and MDGS are the three stocks most similar to BONE BIOLOGICS CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BBLG a Buy, Hold or Sell? See the POWR Ratings now!